Clinical Trials Directory

Trials / Completed

CompletedNCT05165147

Analysis the Positive Rate of Tumor Markers Among Physical Examination Population

Analysis the Positive Status of Tumor Markers Among Physical Examination Population in a Tertiary Grade A Class Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
26,891 (actual)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To analyze the positive rate of tumor markers (TM) among health examination population in a tertiary grade A class hospital, compare the differences between different age and sex groups, and explore the possible influencing factors of TM positive.

Detailed description

From January 2019 to December 2019, who underwent physical examination in Peking University Third Hospital were included in the study. The expression levels of carcinoembryonic antigen (CEA),α-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen-125 (CA-125), carbohydrate antigen 72-4(CA 72-4), carbohydrate antigen 15-3 (CA 15-3), carbohydrate antigen 242(CA 242), squamous cell carcinoma antigen(SCC), CYFRA21-1, total prostate-specific antigen (TPSA ) , free prostate-specific antigen(FPSA), neuron specific enolase(NSE) were detected by Electro chemistry luminescence method. The positive rates of TM were analyzed by descriptive statistical method Explore. The differences between different age and sex groups and the influencing factors were explored by statistic by Inferential statistical method.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2019-01-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2021-12-21
Last updated
2021-12-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05165147. Inclusion in this directory is not an endorsement.

Analysis the Positive Rate of Tumor Markers Among Physical Examination Population (NCT05165147) · Clinical Trials Directory